MDxHealth ADR: EPS is estimated at 0.15 $

Investing.com – MDxHealth-ADR (NASDAQ: ) I reported a quarter of EPS of -$0.420, $0.15 worse than analysts’ estimate of -$0.270.

If the fourth generation is believed to be worth $22.16 million, the debt burden will be $20.81 million.

The MDxHealth ADR stock has received its official trading close at 3.27$. In the last 3 months the performance was plus 19.780%, in the last 12 months it was minus -8.400%.

MDxHealth ADR has had 1 positive EPS revision and 0 negative EPS revision in the last 90 days. The early reactions of the MDxHealth ADR Action Cures to the sales invoices could be a fact here.

InvestingPro supports the financing of MDxHealth ADR on the Grundlage financing knowledge as “gut”.

Information about the MDxHealth ADR can be found here.

All balance dates and results can be found in our balance calendar, for a large number of companies in a real-time activated world.